New Immunosuppressive Therapies in Uveitis Treatment
AbstractUveitis is an inflammatory process that initially starts in the uvea, but can also affect other adjacent eye structures, and is currently the fourth cause of blindness in developed countries. Corticoids are probably the most widespread treatment, but resorting to other immunosuppressive treatments is a frequent practice. Since the implication of different cytokines in uveitis has been well demonstrated, the majority of recent treatments for this disease include inhibitors or antibodies against these. Nevertheless, adequate treatment for each uveitis type entails a difficult therapeutic decision as no clear recommendations are found in the literature, despite the few protocolized clinical assays and many case-control studies done. This review aims to present, in order, the mechanisms and main indications of the most modern immunosuppressive drugs against cytokines. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Mérida, S.; Palacios, E.; Navea, A.; Bosch-Morell, F. New Immunosuppressive Therapies in Uveitis Treatment. Int. J. Mol. Sci. 2015, 16, 18778-18795.
Mérida S, Palacios E, Navea A, Bosch-Morell F. New Immunosuppressive Therapies in Uveitis Treatment. International Journal of Molecular Sciences. 2015; 16(8):18778-18795.Chicago/Turabian Style
Mérida, Salvador; Palacios, Elena; Navea, Amparo; Bosch-Morell, Francisco. 2015. "New Immunosuppressive Therapies in Uveitis Treatment." Int. J. Mol. Sci. 16, no. 8: 18778-18795.